3i5n
From Proteopedia
Line 1: | Line 1: | ||
- | + | {{Seed}} | |
+ | [[Image:3i5n.jpg|left|200px]] | ||
- | The | + | <!-- |
+ | The line below this paragraph, containing "STRUCTURE_3i5n", creates the "Structure Box" on the page. | ||
+ | You may change the PDB parameter (which sets the PDB file loaded into the applet) | ||
+ | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | ||
+ | or leave the SCENE parameter empty for the default display. | ||
+ | --> | ||
+ | {{STRUCTURE_3i5n| PDB=3i5n | SCENE= }} | ||
- | + | ===Crystal structure of c-Met with triazolopyridazine inhibitor 13=== | |
- | Description: Crystal structure of c-Met with triazolopyridazine inhibitor 13 | ||
- | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed | + | <!-- |
+ | The line below this paragraph, {{ABSTRACT_PUBMED_19819693}}, adds the Publication Abstract to the page | ||
+ | (as it appears on PubMed at http://www.pubmed.gov), where 19819693 is the PubMed ID number. | ||
+ | --> | ||
+ | {{ABSTRACT_PUBMED_19819693}} | ||
+ | |||
+ | ==Disease== | ||
+ | Known disease associated with this structure: Hepatocellular carcinoma, childhood type OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=164860 164860]], Renal cell carcinoma, papillary, familial and sporadic OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=164860 164860]], Autism, suseptibility to, 9 OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=164860 164860]] | ||
+ | |||
+ | ==About this Structure== | ||
+ | 3I5N is a 1 chain structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3I5N OCA]. | ||
+ | |||
+ | ==Reference== | ||
+ | <ref group="xtra">PMID:19819693</ref><references group="xtra"/> | ||
+ | [[Category: Homo sapiens]] | ||
+ | [[Category: Receptor protein-tyrosine kinase]] | ||
+ | [[Category: Bellon, S F.]] | ||
+ | [[Category: Boezio, A A.]] | ||
+ | [[Category: Long, A M.]] | ||
+ | [[Category: Whittington, D A.]] | ||
+ | [[Category: Alternative splicing]] | ||
+ | [[Category: Atp-binding]] | ||
+ | [[Category: Chromosomal rearrangement]] | ||
+ | [[Category: Disease mutation]] | ||
+ | [[Category: Disulfide bond]] | ||
+ | [[Category: Glycoprotein]] | ||
+ | [[Category: Hgf/sf]] | ||
+ | [[Category: Kinase]] | ||
+ | [[Category: Membrane]] | ||
+ | [[Category: Nucleotide-binding]] | ||
+ | [[Category: Phosphoprotein]] | ||
+ | [[Category: Polymorphism]] | ||
+ | [[Category: Proto-oncogene]] | ||
+ | [[Category: Receptor]] | ||
+ | [[Category: Receptor tyrosine kinase]] | ||
+ | [[Category: Rtk]] | ||
+ | [[Category: Scatter factor receptor]] | ||
+ | [[Category: Transferase]] | ||
+ | [[Category: Transmembrane]] | ||
+ | [[Category: Tyrosine-protein kinase]] | ||
+ | |||
+ | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Jan 13 13:54:31 2010'' |
Revision as of 11:54, 13 January 2010
Contents |
Crystal structure of c-Met with triazolopyridazine inhibitor 13
Template:ABSTRACT PUBMED 19819693
Disease
Known disease associated with this structure: Hepatocellular carcinoma, childhood type OMIM:[164860], Renal cell carcinoma, papillary, familial and sporadic OMIM:[164860], Autism, suseptibility to, 9 OMIM:[164860]
About this Structure
3I5N is a 1 chain structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.
Reference
- Boezio AA, Berry L, Albrecht BK, Bauer D, Bellon SF, Bode C, Chen A, Choquette D, Dussault I, Fang M, Hirai S, Kaplan-Lefko P, Larrow JF, Lin MH, Lohman J, Potashman MH, Qu Y, Rex K, Santostefano M, Shah K, Shimanovich R, Springer SK, Teffera Y, Yang Y, Zhang Y, Harmange JC. Discovery and optimization of potent and selective triazolopyridazine series of c-Met inhibitors. Bioorg Med Chem Lett. 2009 Nov 15;19(22):6307-12. Epub 2009 Sep 27. PMID:19819693 doi:10.1016/j.bmcl.2009.09.096
Page seeded by OCA on Wed Jan 13 13:54:31 2010
Categories: Homo sapiens | Receptor protein-tyrosine kinase | Bellon, S F. | Boezio, A A. | Long, A M. | Whittington, D A. | Alternative splicing | Atp-binding | Chromosomal rearrangement | Disease mutation | Disulfide bond | Glycoprotein | Hgf/sf | Kinase | Membrane | Nucleotide-binding | Phosphoprotein | Polymorphism | Proto-oncogene | Receptor | Receptor tyrosine kinase | Rtk | Scatter factor receptor | Transferase | Transmembrane | Tyrosine-protein kinase